126 related articles for article (PubMed ID: 34224536)
1. Development and Validation of A Liquid Chromatography-Tandem Mass Spectrometry Method to Simultaneously Measure Tacrolimus and Everolimus Concentrations in Kidney Allograft Biopsies After Kidney Transplantation.
Zhang M; Tajima S; Shigematsu T; Noguchi H; Kaku K; Tsuchimoto A; Okabe Y; Egashira N; Ieiri I
Ther Drug Monit; 2022 Apr; 44(2):275-281. PubMed ID: 34224536
[TBL] [Abstract][Full Text] [Related]
2. Validation of an LC-MS/MS method to measure tacrolimus in rat kidney and liver tissue and its application to human kidney biopsies.
Noll BD; Coller JK; Somogyi AA; Morris RG; Russ GR; Hesselink DA; Van Gelder T; Sallustio BC
Ther Drug Monit; 2013 Oct; 35(5):617-23. PubMed ID: 23921430
[TBL] [Abstract][Full Text] [Related]
3. Salting Out-Assisted Liquid-Liquid Extraction for Liquid Chromatography-Tandem Mass Spectrometry Measurement of Tacrolimus, Sirolimus, Everolimus, and Cyclosporine a in Whole Blood.
Kvamsøe MM; Hansen KR; Skadberg Ø; Vethe NT; Brede C
Ther Drug Monit; 2020 Oct; 42(5):695-701. PubMed ID: 32701594
[TBL] [Abstract][Full Text] [Related]
4. Donor
Zhang M; Tajima S; Shigematsu T; Fu R; Noguchi H; Kaku K; Tsuchimoto A; Okabe Y; Egashira N; Masuda S
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340188
[No Abstract] [Full Text] [Related]
5. Simultaneous Determination of Everolimus, Sirolimus, Tacrolimus, and Cyclosporine-A by Mass Spectrometry.
Dinéia Perez J; Sanches Aragão D; Aparecida Ronchi F; Febba AC; Rosso CF; Tedesco-Silva Junior H; Medina de Abreu Pestana JO; Casarini DE
Transplant Proc; 2020 Jun; 52(5):1402-1408. PubMed ID: 32220480
[TBL] [Abstract][Full Text] [Related]
6. Liquid chromatography-tandem mass spectrometry for therapeutic drug monitoring of immunosuppressants and creatinine from a single dried blood spot using the Capitainer® qDBS device.
Deprez S; Van Uytfanghe K; Stove CP
Anal Chim Acta; 2023 Feb; 1242():340797. PubMed ID: 36657891
[TBL] [Abstract][Full Text] [Related]
7. Multiplex Immunosuppressant (ISD) Method for the Measurement of Cyclosporine A, Tacrolimus, Sirolimus/Rapamycin, and Everolimus in Whole Blood Using MassTrak™ Kit.
Zhang A; Conklin SE
Methods Mol Biol; 2024; 2737():307-318. PubMed ID: 38036832
[TBL] [Abstract][Full Text] [Related]
8. Ultra fast liquid chromatography-tandem mass spectrometry routine method for simultaneous determination of cyclosporin A, tacrolimus, sirolimus, and everolimus in whole blood using deuterated internal standards for cyclosporin A and everolimus.
Meinitzer A; Gartner G; Pilz S; Stettin M
Ther Drug Monit; 2010 Feb; 32(1):61-6. PubMed ID: 20010460
[TBL] [Abstract][Full Text] [Related]
9. Determination of tacrolimus in human whole blood in kidney transplant recipients using a rapid and specific LC-MS/MS method.
Hieu TB; Dung NM; Toan PQ; Kien TQ; Van Duc N; Thang LV; Van Tran P; Hop VQ; Phuong NM; Ben NH; Van Khoi N; Nghia TT; Dung VD; Van Thinh N; Hang DTT; Van Men C; Long DD; Su HX
J Clin Lab Anal; 2023 Aug; 37(15-16):e24958. PubMed ID: 37621139
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Drug Monitoring of Everolimus: Comparability of Concentrations Determined by 2 Immunoassays and a Liquid Chromatography Tandem Mass Spectrometry Method.
Shipkova M; Rapp S; Rigo-Bonnin R; Wieland E; Peter A
Ther Drug Monit; 2017 Apr; 39(2):102-108. PubMed ID: 28125504
[TBL] [Abstract][Full Text] [Related]
11. Determination of Tacrolimus Concentration and Protein Expression of P-Glycoprotein in Single Human Renal Core Biopsies.
Krogstad V; Vethe NT; Robertsen I; Hasvold G; Ose AD; Hermann M; Andersen AM; Chan J; Skauby M; Svensson MHS; Åsberg A; Christensen H
Ther Drug Monit; 2018 Jun; 40(3):292-300. PubMed ID: 29578937
[TBL] [Abstract][Full Text] [Related]
12. Best single time point correlations with AUC for cyclosporine and tacrolimus in HIV-infected kidney and liver transplant recipients.
Frassetto LA; Tan-Tam CC; Barin B; Browne M; Wolfe AR; Stock PG; Roland M; Benet LZ
Transplantation; 2014 Mar; 97(6):702-7. PubMed ID: 24389906
[TBL] [Abstract][Full Text] [Related]
13. An isotope dilution LC-MS/MS based candidate reference method for the quantification of cyclosporine A, tacrolimus, sirolimus and everolimus in human whole blood.
Taibon J; van Rooij M; Schmid R; Singh N; Albrecht E; Anne Wright J; Geletneky C; Schuster C; Mörlein S; Vogeser M; Seger C; Pongratz S; Kobold U
Clin Biochem; 2020 Aug; 82():73-84. PubMed ID: 31770523
[TBL] [Abstract][Full Text] [Related]
14. Design and rationale of the ATHENA study--A 12-month, multicentre, prospective study evaluating the outcomes of a de novo everolimus-based regimen in combination with reduced cyclosporine or tacrolimus versus a standard regimen in kidney transplant patients: study protocol for a randomised controlled trial.
Sommerer C; Suwelack B; Dragun D; Schenker P; Hauser IA; Nashan B; Thaiss F
Trials; 2016 Feb; 17():92. PubMed ID: 26888217
[TBL] [Abstract][Full Text] [Related]
15. Development of a Simple and Rapid Method to Measure the Free Fraction of Tacrolimus in Plasma Using Ultrafiltration and LC-MS/MS.
Stienstra NA; Sikma MA; van Dapperen AL; de Lange DW; van Maarseveen EM
Ther Drug Monit; 2016 Dec; 38(6):722-727. PubMed ID: 27805928
[TBL] [Abstract][Full Text] [Related]
16. Liquid chromatography-tandem mass spectrometry outperforms fluorescence polarization immunoassay in monitoring everolimus therapy in renal transplantation.
Moes DJ; Press RR; de Fijter JW; Guchelaar HJ; den Hartigh J
Ther Drug Monit; 2010 Aug; 32(4):413-9. PubMed ID: 20535052
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Relationship Between Concentrations of Tacrolimus Metabolites, 13-O-Demethyl Tacrolimus and 15-O-Demethyl Tacrolimus, and Clinical and Biochemical Parameters in Kidney Transplant Recipients.
Zegarska J; Hryniewiecka E; Zochowska D; Samborowska E; Jazwiec R; Maciej K; Nazarewski S; Dadlez M; Paczek L
Transplant Proc; 2018 Sep; 50(7):2235-2239. PubMed ID: 30177142
[TBL] [Abstract][Full Text] [Related]
18. Validation of a liquid chromatography-mass spectrometric assay for tacrolimus in liver biopsies after hepatic transplantation: correlation with histopathologic staging of rejection.
Capron A; Lerut J; Verbaandert C; Mathys J; Ciccarelli O; Vanbinst R; Roggen F; De Reyck C; Lemaire J; Wallemacq PE
Ther Drug Monit; 2007 Jun; 29(3):340-8. PubMed ID: 17529892
[TBL] [Abstract][Full Text] [Related]
19. Low plasma concentrations of albumin influence the affinity column-mediated immunoassay method for the measurement of tacrolimus in blood during the early period after liver transplantation.
Tempestilli M; Di Stasio E; Basile MR; Elisei F; Antonini M; Ettorre GM; Iappelli M; Pucillo LP
Ther Drug Monit; 2013 Feb; 35(1):96-100. PubMed ID: 23191996
[TBL] [Abstract][Full Text] [Related]
20. Analytical performance of a new liquid chromatography/tandem mass spectrometric method for determination of everolimus concentrations in whole blood.
McMillin GA; Johnson-Davis K; Dasgupta A
Ther Drug Monit; 2012 Apr; 34(2):222-6. PubMed ID: 22322402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
